Clinical Trial Update: MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee [NA]

View source ↗

Summary

This clinical trial update notes the MaioRegen Prime study for treating deep osteochondral lesions of the knee, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteochondral Lesions of the Knee
• Osteochondritis Dissecans

Drugs mentioned

• MaioRegen Prime (MaioRegen Prime)

Snippet

Sponsor: Fin-Ceramica Faenza Spa | Conditions: Osteochondral Lesions of the Knee Joint, Osteochondritis Dissecans (OCD) | NA | Status: NOT_YET_RECRUITING